Racial and ethnic differences in survival of children with acute lymphoblastic leukemia

Blood

Volumn 100, Issue 6, 2002, Pages 1957-1964

  Bhatia, Smita ^a,b,c,d,e,f   Sather, Harland N ^a,b,c,d,e,f   Heerema, Nyla A ^a,b,c,d,e,f   Trigg, Michael E ^a,b,c,d,e,f   Gaynon, Paul S ^a,b,c,d,e,f   Robison, Leslie L ^a,b,c,d,e,f  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; ETHNIC GROUP; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIOECONOMICS; TREATMENT OUTCOME;

EID: 0037105454     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0395     Document Type: Article

References (46)

1. Incidence of cancer in children in the United States: Sex-, race- and 1-year age-specific rates by histologic type
2. Acute lymphoblastic leukemia
3. Survival of children and adolescents with acute lymphoid leukemia: A study of American Indians and Hispanics and non-Hispanic whites treated in New Mexico (1969 to 1986)
4. Ethnicity and survival in children with acute lymphoid leukemia
5. Ethnicity and cure rates of Texas children with acute lymphoid leukemia
6. Poor prognosis in Negro children with acute lymphocytic leukemia
7. U.S. childhood cancer survival, 1973-1987
8. Racial variation in the frequency of immunological subtypes of childhood acute lymphoblastic leukemia
9. Differences in the presentation of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in black children and white children: A report from the Epidemiology Committee of the Children's Cancer Study Group
10. Clinical and phenotypic features of childhood acute lymphocytic leukemia in whites, blacks, and Hispanics: A Pediatric Oncology Group study
11. Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukemia: Implications for treatment outcome
12. Outcome of treatment for childhood cancer in black as compared with white children: The St. Jude Children's Research Hospital experience 1962 through 1992
13. Should therapy be intensified for patients with good risk ALL?
14. Double delayed intensification improves outcome in moderate risk pediatric acute lymphoblastic leukemia (ALL): A Children's Cancer Group study, CCG-1891
15. Improved outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: A Children's Cancer Group study
16. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: A Children's Cancer Group study
17. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia
18. Dexamethasone (DEX) decreases central nervous system (CNS) relapse and improves event-free survival (EFS) in lower risk acute lymphoblastic leukemia (ALL)
19. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group
20. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy
21. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: A report from the Children's Cancer Group
22. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: Randomized controlled trial from the Children's Cancer Group
23. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: A report from the Children's Cancer Group
24. Breast-feeding and risk of childhood acute leukemia
25. Nonparametric estimation from incomplete observations
26. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: Analysis and examples
27. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia
28. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study
29. Treatment of acute lymphoblastic leukemia: 30 Years' experience at St. Jude Children's Research Hospital
30. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia
31. Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia
32. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group
33. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: A report from the Children's Cancer Group
34. Biology and treatment of acute lymphoblastic leukemia
35. The increasing disparity in mortality between socio-economic groups in the United States, 1960 and 1986
36. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children
37. Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia
38. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia
39. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia
40. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations
41. Polymorphism of the thiopurine S-methyltransferase gene in blacks
42. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: Ethnic distribution and implications for prostate cancer risk; mutations in brief no. 191